BackMiddle East Pharmaceutical Industries Company Overview

Middle East Pharmaceutical Industries Company Current Cash

Track Middle East Pharmaceutical Industries Company's current cash ($16M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$15.52M
↓ 36.06% YoYΔ $-8.75M vs prior year quarter

Peer trimmed avg / median

Loading

Middle East Pharmaceutical Industries Company Current Cash History

Loading

Middle East Pharmaceutical Industries Company vs. peers: Current Cash Comparison

Loading

Middle East Pharmaceutical Industries Company Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Middle East Pharmaceutical Industries Company (4016.SR) FAQ

As of the most recent data (June 2026), 4016.SR shows a current cash of $16M. That compares with $24M in the prior-year period — down 36.1% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, 4016.SR's current cash is now $16M (was $24M) — a 36.1% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Middle East Pharmaceutical Industries Company is outperforming or lagging.

Tracking 4016.SR's current cash over time shows whether Middle East Pharmaceutical Industries Company is scaling, shrinking, or reshaping that part of the business. The current reading is $16M That compares with $24M in the prior-year period — down 36.1% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current cash page, Stockcircle has Middle East Pharmaceutical Industries Company's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current cash (currently $16M) with ownership activity and broader fundamentals.